wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q27650259-5228F631-09F2-45EC-BEA6-8300F9CABAB7
Q27650259-5228F631-09F2-45EC-BEA6-8300F9CABAB7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27650259-5228F631-09F2-45EC-BEA6-8300F9CABAB7
Matuzumab Binding to EGFR Prevents the Conformational Rearrangement Required for Dimerization
P2860
Q27650259-5228F631-09F2-45EC-BEA6-8300F9CABAB7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27650259-5228F631-09F2-45EC-BEA6-8300F9CABAB7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4cf83a1f4f43e73cea5f96d1909f1b494fb79550
P2860
Phase I study of the humanised anti-EGFR monoclonal antibody matuzumab (EMD 72000) combined with gemcitabine in advanced pancreatic cancer.